Vendor Evaluation Framework

Pharmaceutical Software Vendor Evaluation Scorecard

Objective vendor comparison framework used by 200+ pharma companies to select software

How to Use This Scorecard

List your vendors (3-5 max for manageable evaluation)
Adjust weights based on your priorities (must total 100%)
Score each vendor from 1-5 for each criterion
Calculate weighted scores automatically
Document justification for audit trail

Section 1: Compliance & Validation (Weight: 30%)

Non-negotiables for pharmaceutical software

Criterion	What to Evaluate	Red Flags
21 CFR Part 11 Compliance	Audit trail completeness E-signature capabilities Access controls Data integrity features	"Partial compliance" Custom development needed No validation package
Validation Documentation	IQ/OQ/PQ protocols provided Validation time estimate Previous FDA inspections passed	"You write, we review" No templates >6 month timeline
Regulatory History	Warning letters 483 observations Reference site inspections	Any warning letter Multiple 483s No references
Data Integrity Controls	ALCOA+ adherence Backup/recovery procedures Change control process	Manual processes No disaster recovery Weak audit trails

Section 2: Total Cost of Ownership (Weight: 25%)

Real costs beyond the sales quote

Criterion	What to Evaluate	Hidden Costs
License Model	Per user vs enterprise Concurrent vs named users Module-based pricing	Annual increases Module add-ons User tier jumps
Implementation Costs	Professional services Internal resource needs Timeline reality	Change orders Extended timelines Travel expenses
Validation Costs	Vendor support level Documentation provided Consultant requirements	Extra validation Annual revalidation Upgrade validation
Ongoing Costs	Maintenance % Support tiers Training needs	Premium support Admin overhead Upgrade fees

Section 3: Technical Fit (Weight: 20%)

Architecture and integration reality

Criterion	What to Evaluate	Technical Debt
Integration Capabilities	API availability Standard protocols Existing connectors	Custom only Limited APIs Batch-only
Architecture	Cloud vs on-premise Scalability Performance benchmarks	Legacy tech Single server No redundancy
Configuration Flexibility	No-code configuration Workflow builder Forms designer	Code required Vendor dependency Rigid workflows
Future-Proofing	Roadmap alignment Technology stack Company stability	No roadmap Old tech stack Acquisition risk

Section 4: Implementation & Support (Weight: 15%)

Post-signature reality

Criterion	What to Evaluate	Warning Signs
Implementation Team	Dedicated PM Industry experience Resource availability	Offshore only Junior team Overcommitted
Knowledge Transfer	Training approach Documentation quality Admin training depth	"Train the trainer" Generic docs Extra cost
Support Model	Response times Escalation path Support hours/location	Ticket-only Offshore nights No phone
User Community	User group existence Community size Resource sharing	No community Vendor-only forum Dead forums

Section 5: Vendor Viability (Weight: 10%)

Long-term partnership risks

Criterion	What to Evaluate	Risk Factors
Financial Stability	Years in business Customer base size Revenue growth	<5 years old <50 customers VC dependency
Pharma Focus	% pharma clients Industry expertise Regulatory awareness	<30% pharma Generic approach No SMEs
References	Similar size/scope Recent implementations Contact availability	Old references Different industry Reluctant refs
Company Direction	Product investment Strategic alignment Acquisition activity	Maintenance mode Pivot risk PE ownership

Scoring Guide & Decision Framework

Scoring Scale (1-5):

Excellent - Exceeds requirements, best-in-class

Good - Meets all requirements, minor gaps

Acceptable - Meets core requirements, some concerns

Poor - Significant gaps, major concerns

Unacceptable - Fails requirements, dealbreaker

Decision Framework:

Score 4.0+: Strong candidate, proceed with confidence

Score 3.5-3.9: Acceptable with risk mitigation

Score 3.0-3.4: Significant concerns, negotiate improvements

Score <3.0: Recommend against selection

Questions Vendors Hate (But Must Answer)

1. "Show us your last 3 FDA inspection outcomes at client sites"

Tests regulatory track record and transparency

2. "What's included in base price vs additional cost?"

Reveals hidden costs and pricing structure

3. "How many implementations have gone over timeline/budget?"

Uncovers realistic implementation expectations

4. "Can we speak to your most recent failed implementation?"

Assesses honesty and learning from failures

5. "What happens to our data if you're acquired?"

Tests data ownership and exit strategy

Must-Have Checklist & Deal Breakers

Must-Have Checklist:

FDA inspection within last 3 years

Live reference site visit possible

Validation package included

Disaster recovery demonstrated

Security audit passed

Deal Breakers (Automatic Disqualification):

No audit trail

Cannot demonstrate compliance

No pharma experience

Incomplete validation docs

Acquisition in progress

Start Your Vendor Evaluation

Browse pharmaceutical software vendors to build your comparison list. Use this scorecard framework to objectively evaluate each vendor.

Quality Management Systems (QMS)

CAPA, document control, change control, deviation management

Laboratory Information Systems (LIMS)

Sample tracking, OOS investigations, CoA generation

Manufacturing Execution Systems (MES)

Electronic batch records, real-time monitoring, equipment integration

Browse All Software

Explore all pharmaceutical software categories

Last updated: November 2025 | Based on 200+ pharma software implementations

This evaluation framework is provided as a general guide. Adjust weights and criteria based on your organization's specific requirements and priorities.